LncRNA:ENSG00000269821

Official Symbol

KCNQ1OT1  provided by HGNC

Official Full Name

KCNQ1 opposite strand/antisense transcript 1 

Gene ID

10984 

Chromosome

chr11

Start Site

2608328

End Site

2699994

Strand

Assembly

GRCh38

Biotype

lncRNA

Also known as

KCNQ1-AS2|KCNQ10T1|Kncq1|KvDMR1|KvLQT1-AS|LIT1|NCRNA00012 

Summary

Human chromosomal region 11p15.5 contains two clusters of epigenetically-regulated genes that are expressed from only one chromosome in a parent-of-origin manner. Each cluster, or imprinted domain, is regulated by a functionally independent imprinting control region (ICR). The human CDKN1C/KCNQ1OT1 domain is regulated by an ICR located in an intron of KCNQ1, and contains at least eight genes that are expressed exclusively or preferentially from the maternally-inherited allele. The DNA of the ICR is specifically methylated on the maternally-inherited chromosome, and unmethylated on the paternally-inherited chromosome. The ICR contains the promoter of the KCNQ1OT1 gene that is exclusively expressed from the paternal allele. The KCNQ1OT1 transcript is the antisense to the KCNQ1 gene and is a unspliced long non-coding RNA. It interacts with chromatin and regulates transcription of multiple target genes through epigenetic modifications. The transcript is abnormally expressed from both chromosomes in most patients with Beckwith-Wiedemann syndrome, and the transcript also plays an important role in colorectal carcinogenesis. [provided by RefSeq, Apr 2012] 

M6ARegulator:ENSG00000164944

Official Symbol

VIRMA  provided by HGNC

Official Full Name

vir like m6A methyltransferase associated 

m6A Category

writers 

Gene ID

25962 

Chromosome

chr8 

Start Site

94487689 

End Site

94553529 

Strand

Assembly

GRCh38

Biotype

protein coding 

Also known as

KIAA1429|MSTP054|fSAP121 

Summary

NA 

Differentially expressed Detail
Symbol KCNQ1OT1  VIRMA 
Pvalue 7.3e-11  1.7e-13 
Log2FC 1.7e+00  1.0e+00 
Significant UP REGULATED  UP REGULATED 
Correlation coefficient 0.33 
Correlation FDR 5.2e-11